These insights align with our study’s findings on the pivotal role of mitochondrial metabolism in DLBCL progression, positioning SH3BP5 as a key metabolic-immune regulator with translational implications. This evidence concerns the gene SH3BP5 and diffuse large B-cell lymphoma.